Pfizer and BioNTech are expected to file for emergency use authorization with the Food and Drug Administration as early as Tuesday.

Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.